Peter Weijmarshausen is CEO and co-founder of Humane Genomics, where he is building a synthetic-biology platform for cancer-killing RNA viruses. He previously co-founded Shapeways and served as its CEO before becoming a board director. Earlier in his career, he held engineering and technology leadership roles at Sangine and Aramiska.
Peter Weijmarshausen is CEO and co-founder of Humane Genomics, where he is building a synthetic-biology platform for cancer-killing RNA viruses. He previously co-founded Shapeways and served as its CEO before becoming a board director. Earlier in his career, he held engineering and technology leadership roles at Sangine and Aramiska.
Career
Co-founder, CEO, and Board Director at Shapeways from 2007-03 to 2021-09Co-founded Shapeways and served as CEO from 2007 to 2017. Served as a board director from 2017 to 2021. Helped develop Shapeways as a 3D-printing platform and marketplace.